Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Population”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07225140
What this trial is testing

Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery

Who this might be right for
Post Operative Pain, Acute
AFT Pharmaceuticals, Ltd. 180
Large-scale testing (Phase 3)Active Not RecruitingNCT06736691
What this trial is testing

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Who this might be right for
Trichuris Trichiura; InfectionHookworm InfectionAscaris Lumbricoides Infection
Swiss Tropical & Public Health Institute 315
Not applicableUnknownNCT04230655
What this trial is testing

Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon

Who this might be right for
ObesityWeight LossNon-Alcoholic Fatty Liver Disease
Region Örebro County 110
Post-approval studies (Phase 4)Study completedNCT03521635
What this trial is testing

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 98
Large-scale testing (Phase 3)Active Not RecruitingNCT06641076
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 960
Post-approval studies (Phase 4)Study completedNCT02243176
What this trial is testing

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 689
Large-scale testing (Phase 3)Study completedNCT00451217
What this trial is testing

Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 198
Large-scale testing (Phase 3)Study completedNCT03332771
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 954
Not applicableEnded earlyNCT03553732
What this trial is testing

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Who this might be right for
Prostatic Neoplasms
University of California, San Francisco 48
Not applicableStudy completedNCT01993030
What this trial is testing

Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site Wounds

Who this might be right for
Donor Site Wound
Zhejiang Xingyue Biotechnology Co., Ltd. 71
Large-scale testing (Phase 3)Study completedNCT02451098
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

Who this might be right for
Hyperlipidemia
Chong Kun Dang Pharmaceutical 385
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477795
What this trial is testing

Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients

Who this might be right for
Takayasu ArteritisLarge Vessel Vasculitis
Assistance Publique - Hôpitaux de Paris 52
Not applicableStudy completedNCT03245164
What this trial is testing

The Effects of Group Exercise and Basketball on Obese Children

Who this might be right for
Childhood ObesityPhysical Activity
Eastern Mediterranean University 45
Not applicableUnknownNCT05572099
What this trial is testing

ExoDx Prostate Evaluation in Active Surveillance Patient Population

Who this might be right for
Prostate Cancer
Exosome Diagnostics, Inc. 750
Post-approval studies (Phase 4)Study completedNCT02512523
What this trial is testing

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT02008513
What this trial is testing

Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

Who this might be right for
Alzheimer´s Disease
Affiris AG 194
Large-scale testing (Phase 3)Active Not RecruitingNCT06975878
What this trial is testing

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 1,092
Testing effectiveness (Phase 2)Ended earlyNCT01569074
What this trial is testing

Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 163
Not applicableLooking for participantsNCT06702774
What this trial is testing

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

Who this might be right for
Tuberculosis (TB)
University of Toronto 72,000
Post-approval studies (Phase 4)Study completedNCT02788474
What this trial is testing

Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 347
Next Page